Anastasia Tanti, Author at Domain Therapeutics Group

Scroll to explore

Scroll back top

13 November 2025

Domain Therapeutics Appoints Boston-Based Pharma Leader Jean-Marie Cuillerot, M.D., as Chief Medical...

28 October 2025

Domain Therapeutics Doses First Patients in Phase I / II Trial of DT-7012 Targeting CCR8 in Solid Tu...

Domain Therapeutics featured on Base to Base Biotech podcast

Drug Target Review – Outsmarting immune suppression through GPCR innovation

pharmaphorum – BIO Boston 2025 is shaping up to be a year of challenge – but also opportunity, s...